These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17390566)

  • 1. Hug drug or thug drug? Ecstasy use and aggressive behavior.
    Reid LW; Elifson KW; Sterk CE
    Violence Vict; 2007; 22(1):104-19. PubMed ID: 17390566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?
    Hoshi R; Pratt H; Mehta S; Bond AJ; Curran HV
    J Psychopharmacol; 2006 Mar; 20(2):291-301. PubMed ID: 16510487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current and ex-ecstasy users with polydrug and drug-naive controls.
    Hoshi R; Cohen L; Lemanski L; Piccini P; Bond A; Curran HV
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):351-8. PubMed ID: 17696682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
    Huxster JK; Pirona A; Morgan MJ
    J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.
    Verheyden SL; Maidment R; Curran HV
    J Psychopharmacol; 2003 Dec; 17(4):371-8. PubMed ID: 14870948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced intensity dependence and aggression history indicate previous regular ecstasy use in abstinent polydrug users.
    Wan L; Baldridge RM; Colby AM; Stanford MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1484-90. PubMed ID: 19703509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users.
    Leslie EM; Smirnov A; Cherney A; Wells H; Legosz M; Kemp R; Najman JM
    Addict Behav; 2017 Jul; 70():27-34. PubMed ID: 28182965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young adults' trajectories of Ecstasy use: a population based study.
    Smirnov A; Najman JM; Hayatbakhsh R; Plotnikova M; Wells H; Legosz M; Kemp R
    Addict Behav; 2013 Nov; 38(11):2667-74. PubMed ID: 23899430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
    Lamers CT; Bechara A; Rizzo M; Ramaekers JG
    J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users.
    Curran HV; Rees H; Hoare T; Hoshi R; Bond A
    Psychopharmacology (Berl); 2004 May; 173(3-4):425-33. PubMed ID: 14735288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.
    Davis AK; Rosenberg H
    J Psychoactive Drugs; 2014; 46(2):154-61. PubMed ID: 25052792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is emotional intelligence impaired in ecstasy-polydrug users?
    Craig L; Fisk JE; Montgomery C; Murphy PN; Wareing M
    J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("Ecstasy") use history: psychobiological correlates.
    Gerra G; Zaimovic A; Ampollini R; Giusti F; Delsignore R; Raggi MA; Laviola G; Macchia T; Brambilla F
    J Subst Abuse; 2001; 13(4):471-91. PubMed ID: 11775077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
    Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ
    J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression.
    Zacher A; Zimmermann J; Cole DM; Friedli N; Opitz A; Baumgartner MR; Steuer AE; Verdejo-Garcia A; Stock AK; Beste C; Quednow BB
    Eur Neuropsychopharmacol; 2024 Jun; 83():43-54. PubMed ID: 38642447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.